IGA VASCULITIS

Clinical trials for IGA VASCULITIS explained in plain language.

Never miss a new study

Get alerted when new IGA VASCULITIS trials appear

Sign up with your email to follow new studies for IGA VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Completed 1

New combo therapy aims to tame rare blood vessel disease with fewer steroid side effects

Disease control Completed

This study tested whether adding rituximab to standard steroid treatment helps adults with IgA vasculitis (a rare blood vessel disease) achieve remission without needing long-term steroids. 75 adults with new or relapsing severe disease took part. The goal was to see if the combi…

Matched conditions: IGA VASCULITIS

Phase: PHASE3 • Sponsor: Hopital Foch • Aim: Disease control

Last updated Jun 15, 2026 19:06 UTC

IGA VASCULITIS

Get alerted when new IGA VASCULITIS trials appear

New combo therapy aims to tame rare blood vessel disease with fewer steroid side effects